SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-333123
Filing Date
2013-08-14
Accepted
2013-08-13 19:28:08
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d556172d10q.htm 10-Q 633963
2 EX-31.1 d556172dex311.htm EX-31.1 6972
3 EX-32.1 d556172dex321.htm EX-32.1 4657
  Complete submission text file 0001193125-13-333123.txt   6510050

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgls-20130630.xml EX-101.INS 611423
5 XBRL TAXONOMY EXTENSION SCHEMA rgls-20130630.xsd EX-101.SCH 35673
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20130630_cal.xml EX-101.CAL 47516
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20130630_def.xml EX-101.DEF 234181
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20130630_lab.xml EX-101.LAB 320087
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20130630_pre.xml EX-101.PRE 270142
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 131034512
SIC: 2834 Pharmaceutical Preparations